<DOC>
	<DOCNO>NCT00852644</DOCNO>
	<brief_summary>RATIONALE : Stereotactic radiosurgery send x-ray directly tumor cause less damage normal tissue . PURPOSE : This phase I trial study side effect best dose stereotactic radiosurgery treat patient stage I stage II non-small cell lung cancer .</brief_summary>
	<brief_title>Stereotactic Radiosurgery Treating Patients With Stage I Stage II Non-Small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : - To establish maximum tolerate dose CyberKnife® hypofractionated stereotactic radiosurgery patient medically inoperable , stage I II non-small cell lung cancer . - To establish relationship PET response local control survival use fludeoxyglucose F 18 PET/CT image treatment 1 , 3 , 6 , 12 month treatment . OUTLINE : Patients undergo placement 3 gold fiducial marker CT-guidance bronchoscopy . Patients undergo CyberKnife® hypofractionated stereotactic radiosurgery 45-120 minute twice weekly 2 week . Patients undergo fludeoxyglucose F 18 PET/CT scan baseline 1 , 3 , 6 , 12 month completion treatment . After completion study treatment , patient follow periodically 4 year .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Fluorodeoxyglucose F18</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm nonsmall cell lung cancer Stage I II disease ( T13 , N0 , M0 ) T2 T3 tumor ≤ 5 cm No T3 tumor involve central chest mediastinum ( chest wall involvement allow ) Tumor deem technically resectable , opinion experience thoracic surgeon , AND patient deem `` medically inoperable '' Patients FDGavidity mediastinal lymph node eligible provide able undergo mediastinoscopy confirm N0 status PATIENT CHARACTERISTICS : ECOG performance status 02 Not pregnant nursing Fertile patient must use effective contraception ≥ 6 month completion study treatment No history contrast allergy No psychological issue would preclude completion study treatment PRIOR CONCURRENT THERAPY : No prior radiotherapy chemotherapy No suspect nodal metastasis falsify mediastinoscopy ( i.e. , hilar mediastinal node either fludeoxyglucose F 18 [ FDG ] avid measure &gt; 1 cm short axis diameter CT scan ) No tumor within touch proximal bronchial tree , define volume 2 cm direction around proximal bronchial tree ( carina , right leave main stem bronchus , right leave upper lobe bronchus , bronchus intermedius , right middle lobe bronchus , lingular bronchus , right leave low lobe bronchus )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>stage I non-small cell lung cancer</keyword>
	<keyword>stage II non-small cell lung cancer</keyword>
</DOC>